Bsenexus Terminal Open Filings terminal →
Conference call BSE: 524816

Natco Pharma Ltd

Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Q2FY27 Earnings Conference Call Transcript